Drug Approval Working Group

The Aquatic Animal Drug Approval Partnership Program works closely with the Association of Fish and Wildlife Agencies’ Drug Approval Working Group. The overall objective of the working group is to provide a national perspective for the oversight and coordination of collaborative research, field tests, data collection, data analysis, and data submittals to the U.S. Food and Drug Administration for approval of priority drugs for use in public and private aquaculture in the United States. The working group is comprised of members from state resource agencies (representing each major geographic region of the U.S.), as well as from USFWS, NOAA, and USGS. The working group is chaired by a state representative, meets twice annually, and reports directly to the Fisheries and Water Resources Policy Committee. 

Partner organizations involved with Aquatic Animal Drug Approval Partnership 

• American Fisheries Society
• American Veterinary Medical Association
• Association of Fish and Wildlife Agencies - Drug Approval Working Group
• DOI – U.S. Geological Survey – Upper Midwest Environmental Sciences Center
• FDA Center for Veterinary Medicine (Animal and Veterinary)
• Fish Culture Section of the American Fisheries Society
• Fish Health Section of the American Fisheries Society
• Great Lakes Fish Health Committee
• National Aquaculture Association
• Northeast Association of Fish and Wildlife Agencies – Fish Health Technical Committee
• Northwest Indian Fisheries Commission
• Pacific Northwest Fish Health Protection Committee
• Regional Aquaculture Centers
• University of Florida – Tropical Aquaculture Laboratory
• USDA – ARS, Harry K. Dupree Stuttgart National Aquaculture Research Center